UroGen Pharma Ltd Stock Forum

$UroGen Pharma Ltd (URGN.US)$
Breakthrough Bladder Cancer Treatment Achieves 83% Response Rate, FDA Decision Coming 2025

$UroGen Pharma Ltd (URGN.US)$
Clinical Trial Results: Cancer Drug Maintains Response for Nearly 4 Years, Surpassing Expectations

$UroGen Pharma Ltd (URGN.US)$
UroGen Announces Unprecedented 82.3% Duration of Response at 12 Months in the ENVISION Trial Investigating UGN-102 as Potentially the First FDA-Approved Non-Surgical Treatment for LG-IR-NMIBC
• Kaplan-Meier Estimate of Duration of Response at 12 Months in Patients Who Achieved a Complete Response at Three Months was 82.3% (95% CI, 75.9%, 87.1%)
• Side Effect Profile Consistent with Previous Clinical Trials of UGN-102
• UroGen will Host a Virt...

$United Therapeutics (UTHR.US)$  Phase 3
$Ironwood Pharmaceuticals (IRWD.US)$  Phase 3
$Liquidia (LQDA.US)$  Phase 3
$United Therapeutics (UTHR.US)$  Phase 3
$MorphoSys (MOR.US)$  Phase 3
$Immunocore (IMCR.US)$  Phase 3
$Crinetics (CRNX.US)$  Phase 3
$UroGen Pharma Ltd (URGN.US)$  Phase 3
$AstraZeneca (AZN.US)$  Phase 3
$AstraZeneca (AZN.US)$  Phase 3
$AstraZeneca (AZN.US)$  Phase 3
$AstraZeneca (AZN.US)$  Phase 3
$Capricor Therapeutics (CAPR.US)$  Phase 3
$Annexon (ANNX.US)$  Phase 3
$Lipocine (LPCN.US)$  Phase 3...

$Strong Global Entertainment (SGE.US)$ $UroGen Pharma Ltd (URGN.US)$ $The Real Good Food (RGF.US)$ $AltC Acquisition (ALCC.US)$ $Integrated Media Technology (IMTE.US)$ $Emergent BioSolutions (EBS.US)$
📊⚡️📊